Hospital-at-Home for Undifferentiated Patients
Undifferentiated patients should NOT be enrolled in hospital-at-home programs until they have been adequately assessed and stabilized in a traditional hospital setting, with clear diagnosis and treatment plan established. Hospital-at-home is designed for patients with specific, well-defined acute conditions who meet strict clinical and social eligibility criteria, not for diagnostic workup of undifferentiated presentations.
Core Eligibility Framework
Clinical Stability Requirements
Before any patient can be considered for hospital-at-home, they must be:
- Metabolically stable with no immediate risk of acute deterioration 1
- Hemodynamically stable without need for vasopressor support or intensive monitoring 2
- Not requiring advanced respiratory support (no need for high-flow oxygen, non-invasive ventilation, mechanical ventilation, or ECLS) 3
- Alert and oriented (or returned to baseline mental status if initially abnormal) 4
Specific Exclusion Criteria
Patients with the following characteristics are NOT suitable for hospital-at-home 5, 6:
- Impaired consciousness or confusion
- Acidosis (pH < 7.35)
- Severe respiratory distress or oxygen saturation concerns requiring intensive monitoring
- Serious co-morbidity requiring hospital-level intervention
- Need for procedures or equipment only available in acute hospital settings
- Hemodynamic instability despite initial treatment
The Assessment Process for Hospital-at-Home
Step 1: Diagnosis Confirmation (Must Occur in Hospital)
The patient must have a confirmed diagnosis of a condition known to be safely manageable at home. Evidence supports hospital-at-home for 5, 6:
- Community-acquired pneumonia
- Exacerbation of chronic heart failure
- Exacerbation of chronic obstructive pulmonary disease
- Cellulitis
- Selected cases of bacteremia (with telemedicine support) 7
Undifferentiated patients requiring diagnostic workup do NOT meet this criterion.
Step 2: Clinical Suitability Assessment
After diagnosis is established, assess 8:
- Response to initial treatment: Patient must demonstrate clinical improvement with standard therapy before transfer
- Procedural needs: Confirm no anticipated need for procedures requiring hospital equipment (imaging, invasive monitoring, etc.)
- Monitoring requirements: Vital signs stable enough for intermittent rather than continuous monitoring
- Medication delivery: Treatment can be safely administered at home (oral medications, subcutaneous injections, or simple IV therapy)
Step 3: Social and Environmental Assessment
The home environment must support safe care delivery 9, 1:
- Adequate living conditions: Clean, safe space with basic utilities
- Social support: Responsible adult available 24/7 or adequate caregiver support
- Geographic accessibility: Patient can reach hospital within 1 hour if condition worsens 2
- Communication capability: Reliable phone/internet access for telemedicine monitoring
- Patient/caregiver capacity: Ability to understand and perform required care procedures after training 1
Step 4: Risk Stratification
Use validated criteria to identify high-risk patients who should remain hospitalized 10:
Ineligibility factors associated with poor outcomes:
- Pulmonary congestion with ischemic chest pain (OR 6.85)
- Acute coexisting illness requiring independent hospitalization (OR 2.66)
- Significant pulmonary congestion persisting after initial treatment (OR 14.4)
- Multiple complications during initial hospital phase
- High procedural intensity anticipated
Implementation Algorithm
For the Undifferentiated Patient:
- Initial presentation → Admit to traditional hospital for evaluation
- Diagnostic workup → Establish clear diagnosis and treatment plan
- Initial stabilization → Treat for 2-4 days minimum in hospital 2
- Response assessment → Confirm clinical improvement and metabolic stability
- Eligibility screening → Apply clinical, social, and environmental criteria
- If eligible → Transfer to hospital-at-home with structured care plan
- If ineligible → Continue traditional hospitalization or discharge home with outpatient follow-up
Minimum Hospital Stay Before Transfer
- Low-risk patients: Median 2 days for solid tumors 2
- Higher-risk patients: Median 5 days for hematologic conditions 2
- COPD exacerbations: Initial assessment and stabilization required before early supported discharge 5
- General medical conditions: Mean 3.7 days in hospital before transfer for eligible patients 10
Required Infrastructure
Hospital-at-home programs require 9, 1:
- Nutrition Support Team or equivalent multidisciplinary team available 24/7
- Specialist respiratory nurses/physiotherapists or trained district nurses 5
- Daily physician oversight (hospitalist and/or specialist) 7
- Registered nurse visits at minimum daily, often twice daily
- Emergency contact system with clear escalation pathways
- Integrated care pathways or assessment protocols 5
Common Pitfalls to Avoid
Premature transfer: Moving patients before adequate stabilization increases readmission risk (28.6% required hospital transfer in bacteremia series) 7
Inadequate social assessment: Failure to verify 24/7 caregiver availability or safe home environment leads to preventable complications
Diagnostic uncertainty: Attempting to use hospital-at-home for diagnostic workup rather than treatment of established conditions
Ignoring exclusion criteria: Enrolling patients with confusion, acidosis, or serious comorbidity significantly increases adverse outcomes 5
Insufficient monitoring: Patients require daily clinical assessment, not just remote monitoring—69% acceptance rate when properly explained 6
Mandatory Follow-up
All hospital-at-home patients require 11:
- Daily evaluation during acute phase by trained clinicians
- Recurrent fever or deterioration → Immediate hospital readmission 2
- Outpatient follow-up within 1-4 weeks after discharge 12, 11
- Early contact (3-5 days) with primary provider to prevent relapse 12
Bottom line: Undifferentiated patients need diagnosis and stabilization in a traditional hospital first. Hospital-at-home is for early supported discharge of selected patients with confirmed diagnoses who have demonstrated clinical response to treatment, NOT for initial evaluation of unclear presentations.